1
Clinical Trials associated with BMS-986410A Phase 1, Open-label, Two-Part Study to Evaluate the Pharmacokinetics, Metabolism and Excretion, and Absolute Bioavailability of BMS-986365 in Healthy Male Participants
The objective of this study is to assess the pharmacokinetics (PK) and absolute bioavailability of BMS-986365 and to investigate the PK, metabolite profile, routes and extent of elimination, and mass balance of BMS-986365.
100 Clinical Results associated with BMS-986410
100 Translational Medicine associated with BMS-986410
100 Patents (Medical) associated with BMS-986410
100 Deals associated with BMS-986410